Table 2. Patients' clinical and pathological characteristics of the whole sample and their associations between the 2 treatment subgroups.
Values are presented as number of cases (%).
APC, anaphase-promoting complex; IHC, immunohistochemistry.
Values are presented as number of cases (%).
APC, anaphase-promoting complex; IHC, immunohistochemistry.